{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:38:54Z","timestamp":1773693534228,"version":"3.50.1"},"reference-count":14,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016827","name":"Deciphera Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.2217\/fon-2023-0238","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T08:51:36Z","timestamp":1692348696000},"page":"593-601","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["The MOTION Study: A Randomized, Phase III Study of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-2796","authenticated-orcid":false,"given":"William D","family":"Tap","sequence":"first","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maitreyi G","family":"Sharma","sequence":"additional","affiliation":[{"name":"Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Vallee","sequence":"additional","affiliation":[{"name":"Biostatistics, Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan D","family":"Smith","sequence":"additional","affiliation":[{"name":"Biological Sciences, Deciphera Pharmaceuticals, LLC, Lawrence, KS 66044, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L","family":"Sherman","sequence":"additional","affiliation":[{"name":"Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Ruiz-Soto","sequence":"additional","affiliation":[{"name":"Clinical Development, Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-7656","authenticated-orcid":false,"given":"Michiel van","family":"de Sande","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, Leiden, 2333, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-774X","authenticated-orcid":false,"given":"R Lor","family":"Randall","sequence":"additional","affiliation":[{"name":"University of California Davis Medical Center, Sacramento, CA 95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3338-5878","authenticated-orcid":false,"given":"Nicholas M","family":"Bernthal","sequence":"additional","affiliation":[{"name":"University of California Los Angeles, Los Angeles, CA 90095, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-8636","authenticated-orcid":false,"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, Leiden, 2333, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2016.11.002"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507321103"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00926-7"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.2196\/ijmr.9325"},{"key":"e_1_3_7_7_1","unstructured":"Daiichi Sankyo Inc. TURALIO\u00ae (pexidartinib) capsules. US prescribing informationUS prescribing information. Basking Ridge NJ USA (October 2021). [cited 21 June 2022]. Available from: https:\/\/daiichisankyo.us\/prescribing-information-portlet\/getPIContent?productName=Turalio&inline=true"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30764-0"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-1475"},{"key":"e_1_3_7_10_1","unstructured":"European Medicines Agency. Assessment report for Turalio. June 25 2020. [cited 21 June 2022]. Available from: www.ema.europa.eu\/en\/documents\/assessment-report\/turalio-epar-refusal-public-assessment-report_en.pdf."},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0804-2"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76094"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0361"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.275"},{"key":"e_1_3_7_15_1","volume-title":"2022 European Society for Medical Oncology (ESMO) Congress.","author":"Blay JY","year":"2022","unstructured":"Blay JY, Gelderblom H, Rutkowski P et al. Efficacy and safety of vimseltinib in tenosynovial giant cell tumor (TGCT): phase 2 expansion. Presented at: 2022 European Society for Medical Oncology (ESMO) Congress. European Society for Medical Oncology, Paris, France (2022)."},{"key":"e_1_3_7_16_1","unstructured":"US Food and Drug Administration. Pilot OCE\/OOD Standard Safety Data Requests v1.3. www.fda.gov\/media\/133252\/download 2021"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:27:29Z","timestamp":1726756049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.2217\/fon-2023-0238"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0238","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}